Cogent Biosciences Inc
Cogent Biosciences Inc (COGT) Option Chain
As of September 22, 2026, Cogent Biosciences Inc is trading at $32.63, a +1.97% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 52.4%. IV Rank is 2%.
Read more
Tracking the COGT option chain helps you see every strike and expiry on Cogent Biosciences Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Cogent Biosciences Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of COGT options activity at a glance. Use our scanner to monitor the COGT option chain in real time and filter for the COGT options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For COGT stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the COGT option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where COGT stock options are being actively traded and where they are not.
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc.
in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Cogent Biosciences Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen COGT options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of COGT stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile20.24% Subdued
- Market cap (M$)5,662
- 52 weeks high-25.38%
- 52 weeks low162.30%
- Analyst recommendationStrong Buy
1.17 - Target price$55.82
71.07% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-06
- P/E—
- Future P/E—
- EPS (ttm)-2.44
- EPS growth next 5 years—
As of September 22, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 43.83 | 0 | 0 | 0.99 | 1.63 | 0.45 | 4.80 | 31.00 | -3.13 | — | 1.35 | 0.00 | 1.35 | 0 | 17 | 56.17 |
| 52.27 | 13 | 559 | 0.89 | 0.63 | 0.85 | 2.20 | 32.00 | 0.00 | 1.35 | 2.80 | 0.00 | 2.08 | 1 | 176 | 47.73 |
| 60.35 | 10 | 0 | 1.30 | 0.00 | 0.15 | 2.45 | 33.00 | +3.13 | 0.50 | 4.70 | 0.37 | 2.23 | 0 | 20 | 39.65 |
| 67.79 | 0 | 0 | 0.85 | 0.00 | 0.20 | 1.50 | 34.00 | +6.25 | 1.50 | 4.30 | 1.37 | 1.53 | 0 | 36 | 32.21 |
| 74.39 | 14 | 255 | 0.80 | 0.00 | — | 0.80 | 35.00 | +9.38 | 2.05 | 4.90 | 2.37 | 1.11 | 2 | 54 | 25.61 |
As of September 22, 2026
Scan the full option chain in one place
Browse the full COGT option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→